Probably not as expensive, but still much more expensive than it need be.

We've got a bunch of perverse incentives where it's cheaper for the patient to choose the option that's more expensive for the payer. Straightening those out would be a small first step, but complexities of the system and incumbent powers have made it pretty difficult.